Page last updated: 2024-08-21

hematoxylin and Rhabdomyosarcoma 2

hematoxylin has been researched along with Rhabdomyosarcoma 2 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Barkauskas, DA; Bode, PK; Brown, GT; Choo-Wosoba, H; Chou, HC; Collins, J; Hall, D; Hawkins, DS; Jung, H; Khan, J; Kuznetsov, IB; Ladanyi, M; Linardic, CM; Lisle, C; Liu, Y; Lo, T; Milewski, D; Rudzinski, ER; Shern, JF; Skapek, SX; Somerville, B; Steinberg, SM; Venkatramani, R; Wei, JS; Zaki, G	1

Other Studies

1 other study(ies) available for hematoxylin and Rhabdomyosarcoma 2

Article	Year
Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group. Clinical cancer research : an official journal of the American Association for Cancer Research, 2023, 01-17, Volume: 29, Issue:2 Topics: Child; Deep Learning; Eosine Yellowish-(YS); Hematoxylin; Humans; Paired Box Transcription Factors; Prospective Studies; Rhabdomyosarcoma; Rhabdomyosarcoma, Alveolar; Young Adult	2023

Article

Year

Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2023, 01-17, Volume: 29, Issue:2

Topics: Child; Deep Learning; Eosine Yellowish-(YS); Hematoxylin; Humans; Paired Box Transcription Factors; Prospective Studies; Rhabdomyosarcoma; Rhabdomyosarcoma, Alveolar; Young Adult

2023